Diagnosis and Treatment of Connective Tissue Diseases: A Clinician's Perspective: 2nd Edition
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Immunology & Rheumatology".
Deadline for manuscript submissions: 20 May 2026 | Viewed by 13
Special Issue Editors
Interests: immunodermatology; autoimmune skin disorders; connective tissue diseases; autoimmune blistering diseases; diagnostic tools in dermatology
Special Issues, Collections and Topics in MDPI journals
Interests: itch; psychodermatology; psoriasis; autoimmune connective tissue disorders
Special Issues, Collections and Topics in MDPI journals
Interests: immunodermatology; autoimmune connective tissue diseases; non-invasive diagnostics of skin diseases
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are excited to announce the launch of the second edition of our Special Issue titled “Diagnosis and Treatment of Connective Tissue Diseases: A Clinician's Perspective”. We invite you to visit our website to access the first volume of this Special Issue, available at https://www.mdpi.com/journal/jcm/special_issues/CD9TL006V9.
Connective tissue diseases (CTDs) encompass a diverse group of autoimmune diseases, including systemic lupus erythematosus (SLE), scleroderma, dermatomyositis, and rarer overlap syndromes. Despite different clinical symptoms, these entities share common pathogenetic mechanisms rooted in abnormal immune responses. Each connective tissue disease manifests through a wide spectrum of symptoms, from the mild involvement of a single system to severe complications affecting multiple organs.
The clinical presentation of CTD is very diverse, making diagnosis challenging. Initial symptoms often include fatigue, joint pain, and skin lesions. Diagnosis is based on a combination of clinical criteria, laboratory tests, and imaging studies. Treatment strategies are designed to manage symptoms and modify the underlying immune dysregulation. The basis of therapy comprises immunosuppressive drugs, corticosteroids, and disease-modifying drugs. Moreover, early intervention and a personalized approach are key in optimizing outcomes.
This picture of the common pathogenesis and distinct clinical profiles of CTD highlights the need for tailored diagnostic and therapeutic strategies. Research is ongoing, with the aim of understanding the complexity of these diseases, identifying new therapeutic options, and improving comprehensive patient care.
The objective of this Special Issue is to offer a comprehensive overview of our evolving understanding of the clinical characteristics and prolonged consequences associated with connective tissue diseases. Contributions will explore disease phenotypes, therapeutic approaches, and biomarkers, aiming to provide an in-depth overview of diverse aspects within the realm of connective tissue diseases.
Prof. Dr. Agnieszka Żebrowska
Prof. Dr. Adam Reich
Prof. Dr. Aleksandra Dańczak-Pazdrowska
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- connective tissue diseases
- lupus erythematosus
- scleroderma
- dermatomyositis
- MCTD
- clinical picture
- spectrum of clinical symptoms
- treatment
- complications
- clinical follow-up
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
